Category:Kidney diseases: Difference between revisions
Jump to navigation
Jump to search
Hudakarman (talk | contribs) |
Hudakarman (talk | contribs) |
||
| Line 13: | Line 13: | ||
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Reviewer name}} | ! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Reviewer name}} | ||
|- | |- | ||
| rowspan=" | | rowspan="34" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Kidney diseases | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Rhabdomyolysis | * Rhabdomyolysis | ||
* Phosphate nephropathy | * Phosphate nephropathy | ||
| Line 43: | Line 33: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
|Abderhalden-Kaufmann-Lignac syndrome | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| | *Abderhalden-Kaufmann-Lignac syndrome | ||
| | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 154: | Line 146: | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Ayesha FJ | | style="padding: 5px 5px; background: #F5F5F5;" |Ayesha FJ | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Sogand | | style="padding: 5px 5px; background: #F5F5F5;" |Sogand | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 159: | Line 249: | ||
|- | |- | ||
|} | |} | ||
==In progress chapters== | ==In progress chapters== | ||
Revision as of 22:51, 19 June 2020
List of Chapters Requiring Content
| Category | Chapters that need content | Assignment Status | Scholar's name | Coach name | Completion Status | Review status | Reviewer name |
|---|---|---|---|---|---|---|---|
| Kidney diseases |
|
||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
Assigned(Rhabdomyolysis) | ||||||
| Ayesha FJ | Sogand | ||||||
|
Nasrin | Elsaiey,Ahmed | |||||
|
Assingned | Ayesha FJ | Sogand | ||||
In progress chapters
| Category | Chapters that need content | Assignment Status | Scholar's name | Coach name | Completion Status | Review status | Reviewer name |
|---|---|---|---|---|---|---|---|
| Kidney diseases | |||||||
Completed chapters
| Category | Chapters that need content | Assignment Status | Scholar's name | Coach name | Completion Status | Review status | Reviewer name |
|---|---|---|---|---|---|---|---|
| Kidney diseases | |||||||
Pages in category "Kidney diseases"
The following 200 pages are in this category, out of 853 total.
(previous page) (next page)A
- Abderhalden-Kaufmann-Lignac syndrome
- Abderhalden-Kaufmann-Lignac syndrome historical perspective
- Abderhalden-Kaufmann-Lignac syndrome history and symptoms
- Abderhalden-Kaufmann-Lignac syndrome overview
- Acute renal failure (patient information)
- Acute renal failure case study one
- Acute renal failure causes
- Acute renal failure classification
- Acute renal failure cost-effectiveness of therapy
- Acute renal failure CT
- Acute renal failure definition
- Acute renal failure differential diagnosis
- Acute renal failure electrocardiogram
- Acute renal failure epidemiology and demographics
- Acute renal failure future or investigational therapies
- Acute renal failure historical perspective
- Acute renal failure history and symptoms
- Acute renal failure laboratory findings
- Acute renal failure medical therapy
- Acute renal failure MRI
- Acute renal failure natural history, complications and prognosis
- Acute renal failure other diagnostic studies
- Acute renal failure other imaging findings
- Acute renal failure overview
- Acute renal failure pathophysiology
- Acute renal failure physical examination
- Acute renal failure primary prevention
- Acute renal failure risk factors
- Acute renal failure screening
- Acute renal failure secondary prevention
- Acute renal failure surgery
- Acute renal failure ultrasound
- Alport syndrome
- Alport syndrome case study one
- Alport syndrome causes
- Alport syndrome cost-effectiveness of therapy
- Alport syndrome diagnostic criteria
- Alport syndrome differential diagnosis
- Alport syndrome echocardiography or ultrasound
- Alport syndrome epidemiology and demographics
- Alport syndrome future or investigational therapies
- Alport syndrome historical perspective
- Alport syndrome history and symptoms
- Alport syndrome laboratory findings
- Alport syndrome medical therapy
- Alport syndrome natural history, complications and prognosis
- Alport syndrome other diagnostic studies
- Alport syndrome overview
- Alport syndrome pathophysiology
- Alport syndrome physical examination
- Alport syndrome primary prevention
- Alport syndrome secondary prevention
- Alport syndrome surgery
- Aminoaciduria
- Analgesic nephropathy
- Analgesic nephropathy case study one
- Analgesic nephropathy causes
- Analgesic nephropathy cost-effectiveness of therapy
- Analgesic nephropathy CT
- Analgesic nephropathy CT scan
- Analgesic nephropathy diagnostic study of choice
- Analgesic nephropathy differential diagnosis
- Analgesic nephropathy electrocardiogram
- Analgesic nephropathy epidemiology and demographics
- Analgesic nephropathy future or investigational therapies
- Analgesic nephropathy historical perspective
- Analgesic nephropathy history and symptoms
- Analgesic nephropathy interventions
- Analgesic nephropathy laboratory findings
- Analgesic nephropathy medical therapy
- Analgesic nephropathy MRI
- Analgesic nephropathy natural history, complications and prognosis
- Analgesic nephropathy other diagnostic studies
- Analgesic nephropathy other imaging findings
- Analgesic nephropathy overview
- Analgesic nephropathy pathophysiology
- Analgesic nephropathy physical examination
- Analgesic nephropathy prevention
- Analgesic nephropathy risk factors
- Analgesic nephropathy screening
- Analgesic nephropathy surgery
- Analgesic nephropathy Ultrasound
- Analgesic nephropathy x-ray
- Azotemia
- Azotemia case study one
- Azotemia cost-effectiveness of therapy
- Azotemia future or investigational therapies
C
D
- Dent's disease
- Dent's disease case study one
- Dent's disease differential diagnosis
- Dent's disease epidemiology and demographics
- Dent's disease future or investigational therapies
- Dent's disease historical perspective
- Dent's disease history and symptoms
- Dent's disease laboratory findings
- Dent's disease medical therapy
- Dent's disease natural history, complications and prognosis
- Dent's disease other diagnostic studies
- Dent's disease overview
- Dent's disease pathophysiology
- Dent's disease physical examination
- Diabetic nephropathy biopsy
- Diabetic nephropathy differentiating diabetic nephropathy from other diseases
- Differentiating Diabetic nephropathy from other diseases
- Differentiating Goodpasture syndrome from other diseases
F
- Fanconi syndrome
- Fanconi syndrome case study one
- Fanconi syndrome cost-effectiveness of therapy
- Fanconi syndrome future or investigational therapies
- Fanconi syndrome history and symptoms
- Fanconi syndrome laboratory findings
- Fanconi syndrome overview
- Fibromuscular dysplasia
- Fibromuscular dysplasia arteriography
- Fibromuscular dysplasia case study one
- Fibromuscular dysplasia cost-effectiveness of therapy
- Fibromuscular dysplasia future or investigational therapies
- Fibromuscular dysplasia management guidelines
- Focal segmental glomerulosclerosis case study one
- Focal segmental glomerulosclerosis chest x ray
- Focal segmental glomerulosclerosis cost-effectiveness of therapy
- Focal segmental glomerulosclerosis CT
- Focal segmental glomerulosclerosis differential diagnosis
- Focal segmental glomerulosclerosis echocardiography or ultrasound
- Focal segmental glomerulosclerosis future or investigational therapies
- Focal segmental glomerulosclerosis history and symptoms
- Focal segmental glomerulosclerosis medical therapy
- Focal segmental glomerulosclerosis MRI
- Focal segmental glomerulosclerosis other diagnostic studies
- Focal segmental glomerulosclerosis other imaging findings
- Focal segmental glomerulosclerosis primary prevention
- Focal segmental glomerulosclerosis secondary prevention
- Focal segmental glomerulosclerosis surgery
G
- Glomerular disease
- Glomerular disease (patient information)
- Glomerulonephritis case study one
- Glomerulonephritis causes
- Glomerulonephritis classification
- Glomerulonephritis cost-effectiveness of therapy
- Glomerulonephritis CT
- Glomerulonephritis differential diagnosis
- Glomerulonephritis echocardiography or ultrasound
- Glomerulonephritis epidemiology and demographics
- Glomerulonephritis future or investigational therapies
- Glomerulonephritis historical perspective
- Glomerulonephritis history and symptoms
- Glomerulonephritis laboratory findings
- Glomerulonephritis medical therapy
- Glomerulonephritis natural history, complications and prognosis
- Glomerulonephritis other diagnostic studies
- Glomerulonephritis other imaging findings
- Glomerulonephritis overview
- Glomerulonephritis pathophysiology
- Glomerulonephritis physical examination
- Glomerulonephritis primary prevention
- Glomerulonephritis risk factors
- Glomerulonephritis screening
- Glomerulonephritis secondary prevention
- Glomerulosclerosis
- Glomerulosclerosis case study one
- Glomerulosclerosis causes
- Glomerulosclerosis classification
- Glomerulosclerosis cost-effectiveness of therapy
- Glomerulosclerosis CT
- Glomerulosclerosis differential diagnosis
- Glomerulosclerosis epidemiology and demographics
- Glomerulosclerosis future or investigational therapies
- Glomerulosclerosis historical perspective
- Glomerulosclerosis history and symptoms
- Glomerulosclerosis laboratory findings
- Glomerulosclerosis medical therapy
- Glomerulosclerosis MRI
- Glomerulosclerosis natural history, complications and prognosis
- Glomerulosclerosis other diagnostic studies
- Glomerulosclerosis other imaging findings
- Glomerulosclerosis overview
- Glomerulosclerosis pathophysiology
- Glomerulosclerosis physical examination
- Glomerulosclerosis primary prevention
- Glomerulosclerosis risk factors
- Glomerulosclerosis screening
- Glomerulosclerosis surgery
- Glomerulosclerosis ultrasound
- Glycosuria
- Goodpasture syndrome
- Goodpasture syndrome case study one
- Goodpasture syndrome causes
- Goodpasture syndrome chest x ray
- Goodpasture syndrome classification
- Goodpasture syndrome cost-effectiveness of therapy
- Goodpasture syndrome CT
- Goodpasture syndrome echocardiography
- Goodpasture syndrome echocardiography or ultrasound
- Goodpasture syndrome electrocardiogram